Elanco Animal Health Incorporated (ELAN) — Insider Activity & Signal

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $12.0B · $24.11 · 52-week range $17.11–$27.98

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

Date	Insider	Role	Shares	Price	Value	Source
2026-08-20	Kurzius Lawrence Erik	director	40,000	$23.40	$935,920	SEC Form 4
2026-08-18	O'Neill Shiv	officer: GC AND CORP SEC	3,998	$23.58	$94,273	SEC Form 4
2026-08-12	Harrington Michael J	director	5,000	$21.82	$109,100	SEC Form 4
2026-08-07	VanHimbergen Robert M	officer: EVP and CFO	4,200	$23.08	$96,926	SEC Form 4
2026-08-07	Herendeen Paul	director	10,000	$23.68	$236,850	SEC Form 4
2026-05-15	Modi Rajeev A.	officer: SEE REMARKS	4,911	$20.35	$99,939	SEC Form 4
2026-05-15	Simmons Jeffrey N	director, officer: PRESIDENT, CEO AND DIRECTOR	4,971	$20.09	$99,843	SEC Form 4

Financial health

Altman Z-Score 1.38 · Piotroski F-Score 5/9 · Cash $545M · Debt $4.0B

ClearOcean signal read

ClearOcean's model currently scores ELAN as a watchlist-level signal (7/10), based on the insider, fundamental and risk data above. This is a factual model output, not advice.

Sources & further reading

Primary filings: SEC EDGAR — ELAN Form 4
How ClearOcean reads insider activity

Last updated August 31, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.